Analyst
Citigroup
Equibles does not estimate personal net worth.
Daniel Grossleit is recorded as Analyst at Citigroup. Daniel Grossleit has spoken on 5 earnings calls across 4 companies, most recently for Accendra Health Inc on May 11, 2026. Those appearances were for Claritev Corp (CTEV), Accendra Health Inc (ACH), Phreesia, Inc. (PHR) and Health Catalyst, Inc. (HCAT). The companies whose calls Daniel Grossleit spoke on are classified in the Healthcare sector.
“Thanks for taking the question, and I'll add my congrats to getting this debt restructuring close to over the line here. A couple questions on slide 60 of the investor presentation that you filed with the restructuring.”
“If you allocate the entire guidance reduction to network solutions, it seems like we're looking at kind of a high single-digit, low double-digit, sorry, high single-digit, low double-digit, year-over-year reduction in revenue.”
“I guess if it's one question, I'd like to maybe ask about the comments you made around the strategic review and the prepared remarks. Does that include the possibility of selling the company?”
“Maybe I'll just stick on the 2026 line of questioning. You know, it does seem like you have a fair amount of visibility now, just given the renewals and all the ACV you have signed.”
“It's nice to hear all the momentum in your pipeline, but it sounds like most of the pipeline, at least the new ones in the pipeline, really going to convert to revenue in 2026.”
Citigroup
Analyst
Transcript header (unverified)
CTEV
Health Information Services · Healthcare
PHR
Health Information Services · Healthcare
Health Information Services · Healthcare
